ProMIS Neurosciences, Inc.

NASDAQ: PMN · Healthcare · Biotechnology

Canadian filerHQ Toronto, ONCIK 0001374339Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH 29DQ —GM —SS 50

v0.1 · 35/100 weight · pillars only

↑ listing tenure, Altman-Z · ↓ return on assets, Piotroski F

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$39.7M

Employees

Market cap

$17.5M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$39.7M-$39.7M2025

Operating income-$40.2M-$40.2M2025

Total assets$9.2M$9.2M2025

Liabilities$10.4M$10.4M2025

Equity-$1.3M-$1.3M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

ProMIS Neurosciences, Inc. earned -$39.7M in FY2025 net income.

Peers · Healthcare

Aytu BioPharma, Inc.53D Perimeter Medical Imaging AI, Inc.39D Oncotelic Therapeutics, Inc.46D Defence Therapeutics Inc.——

Key facts

CEONeil K. Warma

SectorHealthcare

IndustryBiotechnology

HeadquartersToronto, ON

ExchangeNASDAQ: PMN

Employees7

IPO date2007-01-10

Latest filings

8-K2026-05-20 8-K2026-05-12 10-Q2026-05-12 DEF 14A2026-04-09 10-K2026-03-25 8-K2026-03-25 8-K2026-01-30 8-K2025-12-16

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.